Skip to main content
Equibles

MARTINGALE ASSET MANAGEMENT L P

Position in EBS — Emergent BioSolutions Inc.

CIK 936944 BOSTON, MA
Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$656,204
+$103,806 QoQ
Shares Held
78,306
+17.7% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#59
of 194 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority Sole 9% Shared 0% None 91%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARTINGALE ASSET MANAGEMENT L P holds $52,615,067 across 17 Drug Manufacturers - Specialty & Generic names. EBS ranks #14 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 69,799 $11,763,923
2 ALKS
Alkermes plc.
 170,004 $8,908,209
3 AMRX
Amneal Pharmaceuticals, Inc.
 283,033 $4,899,301
4 UTHR
UNITED THERAPEUTICS Corp
 7,622 $4,129,828
5 INDV
Indivior Pharmaceuticals, Inc.
 85,564 $3,510,690
6 SUPN
Supernus Pharmaceuticals, Inc.
 74,348 $3,457,925
7 PCRX
Pacira BioSciences, Inc.
 112,025 $2,842,074
8 ANIP
Ani Pharmaceuticals Inc
 30,741 $2,544,739

All Filings in EBS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $656,204 78,306
2026-03-31 $552,398 66,554
2025-12-31 $715,001 57,848
2025-09-30 $502,404 56,962
2024-06-30 $424,886 62,300
2023-09-30 $271,432 79,833
2023-06-30 $353,623 48,112
2023-03-31 $545,060 52,612
2022-12-31 $485,438 41,104
2022-09-30 $587,426 27,986
2022-06-30 $670,122 21,589
2022-03-31 $886,444 21,589
2021-12-31 $960,208 22,089
2021-09-30 $1,020,727 20,386
2021-06-30 $775,721 12,315